BBIO

NASDAQStock$79.67-0.74 (-0.92%)
Mkt Cap 15.6BP/E Div Yield Beta 0.98Vol 967.2K
52W$48.87
$90.17

ETFs That Hold BBIO (BridgeBio Pharma, Inc.)

1M

-5.29%

3M

+16.39%

6M

+19.84%

YTD

+1.83%

1Y

+63.02%

3Y

+177.89%

5Y

+57.82%

ETFs That Hold BBIO

BridgeBio Pharma, Inc. is held by 113 ETFs. The largest position by market value is in VB (Vanguard Morningstar Small-Cap ETF).

ETFFund NameWeight
REVSColumbia Research Enhanced Value ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.01%
FSEGFidelity Enhanced Small Cap Growth ETF0.09%
REMCColumbia Research Enhanced Mid Cap ETF0.10%
ITDBiShares LifePath Target Date 2030 ETF0.01%
ITDHiShares LifePath Target Date 2060 ETF0.01%
ONEOState Street SPDR Russell 1000 Momentum Focus ETF0.01%
TACUT. Rowe Price Active Core U.S. Equity ETF0.02%
ITDIiShares LifePath Target Date 2065 ETF0.01%
IRTRiShares LifePath Retirement ETF0.00%
STSBiShares Factors US Small Blend Style ETF0.03%
ITDJiShares LifePath Target Date 2070 ETF0.01%
RECIColumbia Research Enhanced Core Premium Income ET0.02%

Excludes leveraged and inverse ETFs.

PreviousPage 6 of 6

Frequently Asked Questions

How many ETFs hold BBIO?
BridgeBio Pharma, Inc. (BBIO) is held by 113 ETFs (excluding leveraged and inverse funds). The largest position by market value is in VB (Vanguard Morningstar Small-Cap ETF).
What is the largest ETF that holds BBIO?
By fund size, VB (Vanguard Morningstar Small-Cap ETF) with $183.40B in AUM holds 0.18% of its portfolio in BBIO, representing $324.4M in market value.
What percentage of HELX is BBIO?
BBIO makes up 3.66% of HELX (Franklin Genomic Advancements ETF), making it one of the largest positions in that fund.
Is BBIO in the S&P 500?
BBIO is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.